Momenta Pharmaceuticals, Inc.
(NASDAQ : MNTA)

( )
MNTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -1.98%242.591.3%$854.07m
MRNAModerna, Inc. -2.27%67.160.0%$716.87m
IMMUImmunomedics, Inc. 0.14%85.1711.0%$669.53m
NVAXNovavax, Inc. -9.01%101.5796.5%$605.16m
GILDGilead Sciences, Inc. -0.49%63.091.0%$573.14m
ILMNIllumina, Inc. 1.67%273.003.5%$451.06m
REGNRegeneron Pharmaceuticals, Inc. -1.11%565.192.7%$438.62m
BIIBBiogen, Inc. -0.21%272.201.6%$337.47m
VRTXVertex Pharmaceuticals, Inc. -1.41%263.821.9%$321.90m
ALXNAlexion Pharmaceuticals, Inc. -1.82%112.432.0%$278.98m
SRNESorrento Therapeutics, Inc. -10.95%9.601.5%$268.90m
MNTAMomenta Pharmaceuticals, Inc. -0.13%52.293.0%$205.05m
VXRTVaxart, Inc. -17.83%7.190.0%$204.43m
SGENSeattle Genetics, Inc. -1.47%179.276.0%$202.41m
BMRNBioMarin Pharmaceutical, Inc. -1.17%78.434.3%$197.61m

Company Profile

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.